Ranbaxy Laboratories still has exclusive rights for Nexium generic: CEO Arun Sawhney

Ranbaxy was first to seek approval from US FDA to sell a cheaper copy of Nexium, gaining exclusive rights to sell it for 6 months after patent expiry.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news